Compare Align Technology, Inc. (ALGN) vs Schwab US Dividend Equity ETF (SCHD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Schwab US Dividend Equity ETF — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Schwab US Dividend Equity ETF trades at $32.51. The key difference: Schwab US Dividend Equity ETF is trading nearer its 52-week high, Align Technology, Inc. nearer its low. Which is the better fit depends on your goals.
| ALGN | SCHD | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $207.19 | $32.83 |
52-Week Low | $124.88 | $26.38 |
Enterprise Value | $11.92B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
SCHD trades at $32.40, up 0.43% today, with a bullish technical signal from moving averages and neutral oscillators. The ETF focuses on U.S. dividend equities, offering a yield around 3.2%, and has shown strong performance in 2026, outpacing the S&P 500. Recent news highlights its appeal for long-term income investors, though some analysts note underperformance concerns versus broader indices.
Outlook remains positive for dividend-focused portfolios, supported by quality stock selection and low fees. Key risks include interest rate sensitivity and market rotation away from value stocks. Institutional sentiment is mixed, with bullish technicals contrasting with fundamental debates on total returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Schwab US Dividend Equity ETF
SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →
